Terminated trial sought to Fine-Tune cancer drug for patients with liver issues

NCT ID NCT05209295

Summary

This early-stage study aimed to understand how moderate or severe liver problems affect the levels of a cancer drug (oral azacitidine) in the body. It planned to compare adults with blood cancers and liver impairment to those with normal liver function. The main goal was to gather data on drug exposure and safety to help guide future dosing for patients with liver issues.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEOPLASMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Local Institution

    Cleveland, Ohio, 44106, United States

  • Local Institution - 0010

    ABB, Buenos Aires F.D., C1199ABB, Argentina

  • Local Institution - 0011

    Pilar, Buenos Aires, 1629, Argentina

  • Local Institution - 0012

    Buenos Aires, 1426, Argentina

  • Local Institution - 0014

    Buenos Aires, Buenos Aires F.D., C1118AAT, Argentina

  • Local Institution - 0015

    Pamplona, Navarre, 31008, Spain

  • Local Institution - 0017

    Barcelona, Barcelona [Barcelona], 08035, Spain

  • Local Institution - 0018

    Badalona, Barcelona [Barcelona], 08916, Spain

  • Local Institution - 0069

    Detroit, Michigan, 48202, United States

  • Local Institution - 0074

    Hamburg, 20246, Germany

  • Local Institution - 0075

    Halle, Saxony-Anhalt, 06120, Germany

  • Local Institution - 0076

    Augsburg, Bavaria, 86156, Germany

  • Local Institution - 0078

    Salamanca, 37007, Spain

  • Local Institution - 0083

    Iowa City, Iowa, 52242, United States

  • Local Institution - 0084

    Bogota, Cundinamarca, 111151, Colombia

  • Local Institution - 0085

    Bogotá, Bogota D.C., 110131, Colombia

  • Local Institution - 0086

    Piedecuesta, Santander Department, 681017, Colombia

  • Local Institution - 9003

    Charlottesville, Virginia, 22903, United States

Conditions

Explore the condition pages connected to this study.